AICDs Effective for Symptoms, Lethal Arrhythmia in Brugada

Share this content:
AICDs Effective for Symptoms, Lethal Arrhythmia in Brugada
AICDs Effective for Symptoms, Lethal Arrhythmia in Brugada

WEDNESDAY, Jan. 10, 2018 (HealthDay News) -- Implantable cardioverter-defibrillators (ICDs) are effective in young patients with symptomatic Brugada syndrome, according to a study published in the Jan. 16 issue of the Journal of the American College of Cardiology.

M. Cecilia Gonzalez Corcia, M.D., from Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, and colleagues investigated clinical features, management, and long-term follow-up (mean, 88 months) of 35 young patients (mean age, 13.9 years) with Brugada syndrome who had an ICD implanted at an age of ≤20 years.

The researchers found that the vast majority of patients (92 percent) were symptomatic, including 29 percent presented with aborted sudden cardiac death and 63 percent with syncope. ICDs treated sustained ventricular arrhythmias in nine patients, including shocks in eight patients (23 percent) and antitachycardia pacing in one patient. An electrical storm caused death in three patients, while seven patients experienced inappropriate shocks and five patients had device-related complications. Independent predictors of appropriate shock occurrence were aborted sudden cardiac death and spontaneous type I electrocardiogram.

"ICD therapy is an effective strategy in young patients with symptomatic Brugada syndrome, treating potentially lethal arrhythmias in >25 percent of patients during follow-up," the authors write.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Jury Awards 4.62B in Johnson  Johnson Talcum Powder Lawsuit

Jury Awards $4.62B in Johnson & Johnson Talcum ...

The award includes $550 million in compensatory damages and $4.14 billion in punitive damages

100 Now Sickened by Salmonella-Tainted Honey Smacks Cereal

100 Now Sickened by Salmonella-Tainted Honey Smacks Cereal

Thirty people have been hospitalized, but no deaths have been reported

Data Support FDA Restrictions on Child Cough and Cold Medicines

Data Support FDA Restrictions on Child Cough and ...

Surveillance data showed more adverse events for children exposed to hydrocodone than codeine

is free, fast, and customized just for you!




Already a member?

Sign In Now »